SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-15-004898
Filing Date
2015-09-16
Accepted
2015-09-16 17:32:00
Documents
1
Period of Report
2015-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7601
  Complete submission text file 0000899243-15-004898.txt   9193
Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Issuer) CIK: 0001590877 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address
Vasista Vittal (Reporting) CIK: 0001652827 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37553 | Film No.: 151110937